NEW YORK , Sept. 17, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ: ACHC).
Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The investigation concerns whether Acadia and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On Sunday, September 1 , 2024, The New York Times published an article entitled "How a Leading Chain of Psychiatric Hospitals Traps Patients." Citing "records reviewed by The Times ", the article reported that "Acadia has lured patients into its facilities and held them against their will, even when detaining them was not medically necessary" and that "[i]n at least 12 of the 19 states where Acadia operates psychiatric hospitals, dozens of patients, employees and police officers have alerted the authorities that the company was detaining people in ways that violated the law," On this news, Acadia's stock price fell $3.
72 per share, or 4.54%, to close at $78.21 per share on September 3, 2024 .
The Pomerantz Firm, with offices in New York , Chicago , Los Angeles , London , and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz , known as the dean of the class action bar, t.